Literature DB >> 4541779

Influence of chloride ions on changes in membrane potential during prolonged application of carbachol to frog skeletal muscle.

D H Jenkinson, D A Terrar.   

Abstract

1. Micro-electrodes were used to follow changes in the membrane potential at the end-plate region of single fibres in narrow strips of frog skeletal muscle exposed to carbachol applied in continuously flowing Ringer solution containing tetrodotoxin (200 nM) and neostigmine (3 muM).2. The depolarizations elicited by carbachol (5-20 muM) usually developed in two phases, the first of which was generally complete within 30 s whereas several min were required for the second.3. Repolarization after carbachol also occurred in two phases, the second of which outlasted the time needed to clear the bath, and varied with the magnitude and duration of the depolarization which carbachol had caused.4. These findings could best be explained in terms of the consequences of net entry of chloride ions into the fibre during the depolarization caused by carbachol. This hypothesis is supported by three lines of evidence:(a) Replacement of the chloride content of the Ringer solution by the less permeant anion isethionate abolished the slow phases of the carbachol response.(b) Reduction of chloride permeability (by lowering pH) caused rapid repolarization during the recovery period after carbachol.(c) When the membrane potential was clamped at the resting level throughout the action of carbachol, so avoiding chloride redistribution, the clamping current records did not show the slow phases attributed to chloride movement.5. Chloride redistribution contributes to the gradual spread of depolarization during prolonged applications of depolarizing agents to skeletal muscle. It also complicates the interpretation of the dose-response relationship, and may make it more difficult to assess the extent to which the receptors become desensitized during the action of agonists applied in the bath.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4541779      PMCID: PMC1776547          DOI: 10.1111/j.1476-5381.1973.tb08334.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  The influence of potassium and chloride ions on the membrane potential of single muscle fibres.

Authors:  A L HODGKIN; P HOROWICZ
Journal:  J Physiol       Date:  1959-10       Impact factor: 5.182

2.  An analysis of the end-plate potential recorded with an intracellular electrode.

Authors:  P FATT; B KATZ
Journal:  J Physiol       Date:  1951-11-28       Impact factor: 5.182

3.  On the application of "a plausible model" of allosteric proteins to the receptor for acetylcholine.

Authors:  A Karlin
Journal:  J Theor Biol       Date:  1967-08       Impact factor: 2.691

4.  Ionic permeability changes induced by some cholinergic agonists on normal and denervated frog muscles.

Authors:  A Feltz; A Mallart
Journal:  J Physiol       Date:  1971-10       Impact factor: 5.182

5.  Muscle membrane depolarization by acetylcholine, choline and carbamylcholine, near and remote from motor end-plates.

Authors:  A Portela; R J Perez; J Vaccari; J C Perez; P Stewart
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

6.  Does curare affect transmitter release?

Authors:  A Auerbach; W Betz
Journal:  J Physiol       Date:  1971-03       Impact factor: 5.182

Review 7.  An electrophysiological approach to drug-receptor mechanisms.

Authors:  R Werman
Journal:  Comp Biochem Physiol       Date:  1969-09-15

8.  On the mechanism of desensitization at cholinergic receptors.

Authors:  H P Rang; J M Ritter
Journal:  Mol Pharmacol       Date:  1970-07       Impact factor: 4.436

9.  On the excitability and cooperativity of the electroplax membrane.

Authors:  J P Changeux; T R Podleski
Journal:  Proc Natl Acad Sci U S A       Date:  1968-03       Impact factor: 11.205

10.  An analysis of acetylcholine responses of junctional and extrajunctional receptors of frog muscle fibres.

Authors:  A Feltz; A Mallart
Journal:  J Physiol       Date:  1971-10       Impact factor: 5.182

View more
  20 in total

1.  A study of desensitization using voltage clamp.

Authors:  P R Adams
Journal:  Pflugers Arch       Date:  1975-10-28       Impact factor: 3.657

2.  Voltage dependence of agonist effectiveness at the frog neuromuscular junction: resolution of a paradox.

Authors:  V E Dionne; C F Stevens
Journal:  J Physiol       Date:  1975-10       Impact factor: 5.182

3.  An analysis of the dose-response curve at voltage-clamped frog-endplates.

Authors:  P R Adams
Journal:  Pflugers Arch       Date:  1975-10-28       Impact factor: 3.657

4.  Factors affecting the time course of decay of end-plate currents: a possible cooperative action of acetylcholine on receptors at the frog neuromuscular junction.

Authors:  K L Magleby; D A Terrar
Journal:  J Physiol       Date:  1975-01       Impact factor: 5.182

5.  Permeability of the post-synaptic membrane of an excitatory glutamate synapse to sodium and potassium.

Authors:  R Anwyl
Journal:  J Physiol       Date:  1977-12       Impact factor: 5.182

6.  Relaxation experiments using bath-applied suberyldicholine.

Authors:  P R Adams
Journal:  J Physiol       Date:  1977-06       Impact factor: 5.182

7.  The effect of chronic neostigmine treatment on channel properties at the rat skeletal neuromuscular junction.

Authors:  M Gwilt; D Wray
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

Review 8.  The role of the sodium pump during prolonged end-plate currents in guinea-pig diaphragm.

Authors:  R Creese; S D Head; D F Jenkinson
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

9.  End-plate channel opening and the kinetics of quinacrine (mepacrine) block.

Authors:  P R Adams; A Feltz
Journal:  J Physiol       Date:  1980-09       Impact factor: 5.182

10.  Spontaneous recovery from depolarizing drugs in rat diaphragm.

Authors:  R Creese; L D Mitchell
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.